Financial Shenanigans

The Forensic Verdict

eClerx Services Limited screens as a Watch (22/100) — a cleanly-cash-generative, founder-controlled mid-cap KPO whose income statement, cash-flow statement, and balance sheet reconcile to each other across more than a decade. The two items that stop this from being a flat-out "Clean" grade are (1) an FY2025 jump in unbilled revenue from ₹207 Cr to ₹294 Cr (+42% against revenue growth of 15%) — flagged as a Key Audit Matter by the newly-appointed statutory auditor — and (2) Rule 11(g) audit-trail gaps across multiple accounting systems for most of FY2025. Offsetting that, eleven-year average CFO/Net Income sits at ≈1.10, FY2026 receivable days reverted from 86 to 59, the auditor rotation (S.R. Batliboi → Price Waterhouse) was a mandatory two-term expiry rather than a stress event, and no restatement, regulatory action, or material weakness opinion has been issued. The single data point that would most change the grade: FY2026 standalone unbilled receivables — if they remain at or above 8% of revenue, this becomes Elevated; if they snap back toward 5-6%, it becomes Clean.

Negative accrual ratio means CFO exceeds reported net income — a quality signal, not a stress signal.

Shenanigans Scorecard

Breeding Ground

The structural conditions look ordinary for a founder-controlled Indian listed IT-services company, with one mild positive (independent chair, independent audit chair) and one mild negative (concentrated promoter holding plus a high inter-company services flow with the US sales subsidiary). Nothing here pre-disposes the financials to manipulation, but a forensic reader must keep the eClerx LLC related-party flow in view because it is the conduit through which group revenue is booked.

The compensation structure deserves a positive note: founder PD Mundhra draws a flat ₹1.7 Cr salary with no performance bonus, and Group CEO Kapil Jain is paid via the UK subsidiary on a £650K salary with a bonus capped at the prior-year basic. That mutes the classic shenanigans incentive — managers paid in aggressive adjusted-EBITDA bonuses — and there is no evidence of a CEO compensation structure that would reward stretching reported earnings.

Earnings Quality

Reported earnings convert into cash on a multi-year average ratio above 1.0 and the accrual ratio is consistently negative — the cleanest possible signal that net income is not being inflated by accruals. The one area worth attention is unbilled revenue, which jumped 42% in FY2025 (₹207 Cr → ₹294 Cr) against revenue growth of 15%. Price Waterhouse, in its first year as statutory auditor, flagged this as a Key Audit Matter and walked through aging and subsequent-billing testing. The auditor issued an unqualified opinion, so the FY25 number was substantiated, but the ratio of unbilled to revenue rose from 7.1% to 8.7% — a level worth watching in FY26.

CFO has tracked or exceeded net income in 9 of the last 12 fiscal years, including 1.21x in FY25 and 1.24x in FY26. No accrual build-up. No reserve gymnastics. No silent earnings smoothing.

The visual gap is small but the ratio matters. Unbilled grew 6.0x faster than revenue in FY25. For a time-and-materials BPM business, unbilled revenue is genuine — work performed in March that has not yet been invoiced — but a 42% step in a single year is the classic "watch this" signal. Two facts reduce the temperature: the new auditor performed effort-estimate and subsequent-billing testing, and the audit opinion is unmodified.

Other income is running 8-11% of operating profit in recent years. Read against a treasury portfolio of ₹1,048 Cr (cash + bank balances + investments at end-FY25), that yield is ordinary, not an earnings prop. There is no evidence of one-time gains, JV income, or below-the-line items being recycled into operating earnings.

Capex runs below depreciation in every year shown. There is no expanding bucket of "other non-current assets" hiding operating costs. The lease accounting under Ind AS 116 produces a right-of-use asset of ₹325 Cr and a matching lease liability of ₹358 Cr at end-FY25 — these flow correctly through depreciation and finance costs, not through hidden capitalisation.

Cash Flow Quality

Operating cash flow is sourced from collections and a normal-looking working-capital cycle, not from supplier stretch or factoring. The FY25 step-up in CFO (+24%) was matched by a step-up in revenue and net income, and was not driven by any one-off — there is no factoring disclosure, no receivable sale, no supplier-finance program, no tax-refund spike.

The debtor-day spike in FY24 (88 days from 61) and the partial reversal in FY25 (86) are the most visible balance-sheet whisper in the dataset. Combined billed plus unbilled receivables / revenue ran 24-25% across FY24-FY25 against a 16-17% historical norm. FY26 debtor days collapsed back to 59 — a cleanly favourable signal that the FY24 step was timing-related rather than a structural collection problem. Working-capital days, however, jumped to 85 in FY26 driven by other liabilities expansion; this is a screener-derived calculation and likely reflects the larger ESOP-trust liability balance, not an operating problem. Read together, the cash-flow statement is doing what it should: collections are happening, but not in a way that fingerprints any cosmetic CFO inflation.

The FY24 investing-cash-flow outflow of ₹483 Cr looks dramatic in isolation but is largely net redeployment of treasury into mutual funds, not acquisitions. FY25 investing turned positive (+₹143 Cr) as a portion of those funds was realised. This is treasury behaviour, not an acquisition-aided CFO story.

Metric Hygiene

eClerx does not run an aggressive non-GAAP framework. Management reports EBITDA, EBITDA margin, dollar revenue growth (constant currency and reported), deal wins, and headcount. There is no "adjusted EBITDA" that excludes recurring stock-based compensation, no "cash earnings", no organic-growth definition that shifts year-to-year, and no metric that has been quietly dropped after deteriorating.

The deal-wins figure should be tracked. Indian IT-services companies routinely conflate TCV-over-life with annualised revenue, and ECLERX's $140M FY25 deal-wins number is not reconciled to revenue. There is no allegation of misstatement here — only that the metric is the kind that can be redefined without disclosure. Track the deal-wins to actual revenue growth: $140M deal wins against $397.6M revenue suggests a healthy backlog if the TCV horizon is 2-3 years, but the calculation needs a definition.

What to Underwrite Next

Five items to track. Two would move the grade up, three would move it down.

Track 1 — Unbilled receivables ratio in the FY2026 balance sheet. Watch the line "Trade receivables — Unbilled" in the consolidated balance sheet. FY25 closed at ₹294 Cr (8.7% of revenue). A return to 5-6% of revenue (the FY21-FY23 range) would clear the FY25 step-up as a timing event and move this file toward "Clean". A persistence at 8% or above, or a further rise, would push the rating to Elevated and require diligence into whether time-and-materials billing cycles have structurally lengthened.

Track 2 — FY2026 Rule 11(g) audit-trail disclosure. The Companies (Audit and Auditors) Rules mandate audit-trail edit-logging effective FY24. ECLERX's FY25 disclosure documented a partial-year gap. Confirm that the FY26 auditor's report contains no Rule 11(g) qualification or that the gaps were remediated for the full year.

Track 3 — Deal-wins definition. If the company changes the TCV horizon or starts reporting ACR-based wins instead of TCV, treat that as a metric-hygiene yellow flag and require reconciliation to revenue growth.

Track 4 — Related-party flow with eClerx LLC. The FY25 ₹356 Cr sales/marketing service charge to the US wholly-owned subsidiary is meaningful (≈10.6% of consolidated revenue). It is eliminated on consolidation, but transfer-pricing disputes are the single most common Indian-IT-services tax exposure. Monitor for any tax demand, advance-pricing-agreement amendment, or contingent-liability change.

Track 5 — Treasury redeployment. With ₹1,048 Cr+ of cash and investments and ongoing buybacks (FY25: 13.75 lakh shares retired) plus a January 2026 1:1 bonus issue (cosmetic, no value change) and an October 2025 buyback program in tranches, watch the equity-share-capital line for unexplained jumps. The FY26 jump from ₹47.65 Cr to ₹92 Cr is the bonus issue capitalising reserves — a reader who does not know this could mistake it for a cash equity raise.

Bottom line for a PM. The accounting risk here is a footnote, not a valuation haircut. Position sizing does not need to be limited on forensic grounds; covenant comfort is irrelevant because the company carries no term debt; required margin of safety does not need to expand from accounting concerns. The forensic file becomes thesis-relevant only if (1) unbilled revenue persists above 8% of revenue, or (2) a Rule 11(g) qualification reappears in FY26, or (3) a transfer-pricing dispute with US tax authorities surfaces around the eClerx LLC service-fee flow. Until then, treat eClerx as a clean compounder whose forensic profile is consistent with its founder-stewardship and conservative capital-allocation history.